
 
 
 
 
 
 
 
 
   
 1. A DNA construct comprising a DNA sequence encoding an enzyme exhibiting dextranase activity, which DNA sequence comprises a) the dextranase encoding part of the DNA sequence shown in SEQ ID NO. 1, and/or the dextranase encoding part of the DNA sequence obtainable from E. coli DSM 10706, or b) an analogue of the DNA sequence shown defined in a) which i) is 80% homologous with the DNA sequence shown in SEQ ID NO. 1 and/or the DNA sequence obtainable from E. coli DSM 10706, or ii) encodes a polypeptide which is at least 80% homologous with the polypeptide encoded by a DNA sequence comprising the DNA sequence shown in SEQ ID NO. 1 and/or the DNA sequence obtainable from E. coli DSM 10706. 
 
     
 2. The DNA construct according to claim 1, in which the DNA sequence is obtainable from a fungal microorganism. 
 
     
 3. The DNA construct according to claim 2, in which the DNA sequence is obtainable from a filamentous fungus or a yeast. 
 
     
 4. The DNA construct according to claim 3, in which the DNA sequence is obtainable from a strain of Paecilomyces or a strain of Penicillium. 
 
     
 5. The DNA construct according to claim 4, in which the DNA sequence is obtainable from Paecilomyces lilacinus, Penicillium lilacinum or Penicillium minioluteum. 
 
     
 6. The DNA construct according to claim 4 or claim 5, in which the DNA sequence is isolated from or produced on the basis of a nucleic acid library of Paecilomyces lilacinus. 
 
     
 7. A DNA construct according to claim 1 and which is substantially as 25 hereinbefore described with reference to any one of the examples. l 
 
     
 8. A recombinant expression vector comprising the DNA construct according to any one of claims 1 to 7. 
 
     
 9. A cell comprising a DNA construct according to any one of claims 1 to 7, or a recombinant expression vector according to claim 8. 
 
     
 10. The cell according to claim 9, which is a filamentous fungus. 
 
     
 11. The cell according to claim 10, wherein the cell belongs to a strain within the genus Aspergillus, Fusarium, Penicillium, or Paecilomyces. 
 
     
 12. The cell according to claim 11, wherein the cell belongs to a strain of Aspergillus niger or Aspergillus oryzae, Fusarium oxysporium, Fusarium graminearum, R sj'>KFusarium sulphureum, Fusarium cerealis or Fusarium venenatum, Penicillium lilacinum or SPenicillium minioluteum or Paecilomyces lilacinus. [R:\LIBAA]07918.doc:tab 
 
     
 13. A method for producing a recombinant enzyme exhibiting dextranase activity, which method comprises cultivating a host cell according to any one of claims 9 to 12 in suitable culture medium under conditions permitting the expression of the DNA construct according to any one of claims 1 to 7 or expression vector according to claim 8, and recovering the enzyme from the culture. 
 
     
 14. A method for producing a recombinant enzyme according to claim 8, which method is substantially as hereinbefore described with reference to any one of the examples. 
 
     
 A recombinant enzyme with dextranase activity encoded by a DNA construct of claims 1 to 7. 
 
     
 16. A recombinant enzyme according to claim 8 and which is substantially as hereinbefore described with reference to any one of the examples. 
 
     
 17. The recombinant enzyme produced according to the method according to claim 13 or claim 14. 
 
     
 18. A composition comprising recombinant dextranase according to any one of claims 15 to 17. 
 
     
 19. An oral care product comprising an enzyme according to any one of claims to 17 or a composition according to claim 18 further comprising ingredients conventionally used in oral care products. S 20. The oral care product according to claim 19, being a dentifrice. 
 
     
 20 
 
     
 21. The oral care product according to claim 20, being a toothpaste, tooth powder or a mouth wash. 
 
     
 22. The oral care product according to any one of claims 19 to 21 further comprising enzyme activities selected from the group of mutanases, oxidases, peroxidases, haloperoxidases, laccases, proteases, endoglucosidases, lipases, amylases, anti-microbial 25 enzymes, and mixtures thereof. 
 
     
 23. An oral care product comprising a recombinant enzyme according to any one of claims 15 to 17 and which is substantially as hereinbefore described with reference to any one of the examples. 
 
     
 24. Use of the recombinant dextranase according to any one of claims 15 to 17 or a composition of claim 18 or oral care product according to any one of claims 19 to 21 for preventing the formation of dental plaque or removing dental plaque. 
 
     
 Use of the recombinant dextranase according to any one of claims 15 to 17 or a composition of claim 18 for hydrolysis of sugar juice or syrup. 
 
     
 26. Use of the recombinant dextranase according to any one of claims 15 to 17 or 35 4 composition according to claim 18 or oral care composition according to any one of claims I-n 19 t 21 for oral care products for animals. [R:\LIBAA]07918.doc:tab 48 
 
     
 27. Use of the recombinant dextranase according to any one of claims 15 to 17 or a composition of claim 18 in food, feed and/or pet food products. Dated 10 March, 2000 Novo Nordisk AIS Patent Attorneys for the ApplicantlNominated Person SPRUSON FERGUSON *0 0* S p .9 S S5 95 S PS *9 S 9 S 9 9 *59* 99*S 9 9 9559 S 595w 9S 59 S p 9 S [R:\L[BAA]0791I8.doc:tab 
 
   
 
 
 
 
 
 
 
 
